Evidence map›Paper›PMID 39698530›Full record

ArticleHealth science reports2024

Uptake of Measles Second Dose Vaccine and Its Associated Factors Among Children Age 24-35 Months in Merhabete Woreda, Ethiopia: 2022: A Cross-Sectional Study.

Ababye Mulatu Wmeskel, Melese Wagaye Zergaw, Hailegiyorgis Geleta Abocherugn

Abstract read
In one paragraph

Article in Health science reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ababye Mulatu WmeskelDepartment of Public Health College of Medicine and Health Sciences, Wollo University Dessie Ethiopia.
Melese Wagaye ZergawDepartment of Nursing Debre Berhan University Asrat Woldeyes Health Sciences Campus Debre Berhan Ethiopia.ORCID 0009-0005-4169-674X
Hailegiyorgis Geleta AbocherugnDepartment of Midwifery Mizan Tepi University College of Health Sciences Tepi Ethiopia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Measles infection in children causes a high degree of morbidity and mortality. Vaccination with two doses of measles vaccine is the best strategy to prevent infection and its spread to other children. However, measles containing vaccination coverage in Ethiopia is below the WHO elimination goal. In this study, our aim was to assess uptake of measles second dose and its associated factors among children's age 24-35 months in Merhabete, North Shoa, Ethiopia, 2022. Methods: A community-based cross-sectional study design was conducted in Merhabete Woreda from June 1 to 30, 2022. A total of 732 children aged 24-35 months were included using a multistage and systematic random sampling technique. Data were collected using a semi-structured, interviewer-administered questionnaire. Verbal informed consent was taken regarding their willingness to participate in the study from the guardians. The information was kept confidential and not shared with a third party. Data entered into EpiData version 4.6 and exported to SPSS version 25. A logistic regression model was used to identify associated factors. AOR with 95% CI and Results: A total of 732 children with a response rate of 94.6% were included; the median age was 28 months. Uptake of measles vaccine second dose was 63.3% (95% CI 60%-67%). Knowledge of measles second dose schedule (AOR = 2.151, 95% CI 1.053-4.396), birth at a healthcare facility (AOR = 3.502, 95% CI 1.58-7.77), > 4 antenatal care visits (ANC) (AOR = 2.56, 95% CI 1.254-5.225), having immunization card (AOR = 9.958 (4.256-23.298), and mother age 25-34 years (AOR = 2.954, 95% CI 1.298-6.721) were significantly associated with the uptake of measles second dose. Conclusion and Recommendation: The uptake of measles second dose vaccine in Merhabete Woreda was below the WHO measles elimination target of > 95%. Variables such as number of antenatal follow-up visits, institutional delivery, knowing the schedule of measles second dose vaccine, maintaining immunization card records, and maternal age were found to be independent predictors of vaccination. Therefore, Woreda Health Office managers should strengthen periodic monitoring and evaluate the implementation of measles second dose vaccine. Health professionals should also improve mother's awareness on measles second dose vaccine schedule and its importance and retain their immunization chart booklet.

Indexed as

factorsmeaslessecond dose

Identifiers

PMID39698530
PMCPMC11652380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.